![Susan P. Perrine](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Susan P. Perrine
Corporate Officer/Principal chez Boston University
Postes actifs de Susan P. Perrine
Sociétés | Poste | Début | Fin |
---|---|---|---|
Boston University | Corporate Officer/Principal | - | - |
Historique de carrière de Susan P. Perrine
Anciens postes connus de Susan P. Perrine
Sociétés | Poste | Début | Fin |
---|---|---|---|
Viracta Subsidiary, Inc.
![]() Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Fondateur | 01/01/2007 | - |
HemaQuest Pharmaceuticals, Inc.
![]() HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/10/2007 | 07/12/2010 |
Fondateur | 05/03/2010 | - |
Formation de Susan P. Perrine
Tufts University | Doctorate Degree |
Harvard University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Israël | 2 |
Opérationnelle
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
HemaQuest Pharmaceuticals, Inc.
![]() HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
Viracta Subsidiary, Inc.
![]() Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
- Bourse
- Insiders
- Susan P. Perrine
- Expérience